Omer Gal, Chief Legal Officer of Nayax Ltd. (NASDAQ:NYAX), filed a Form 4 on September 17, 2026, disclosing the exercise of stock options and the same-day sale of 1,500 ordinary shares on September 16, 2026.

Key Highlights

  • Option exercise: Omer Gal acquired 1,500 ordinary shares on September 16, 2026, via the exercise of a stock option with an exercise price of $21.352 per share (denominated in New Israeli Shekels, converted at the grant-date exchange rate).
  • Same-day sale: All 1,500 shares acquired through the option exercise were sold on the same date at a price of $45.1698 per share on the Tel Aviv Stock Exchange.
  • Currency note: The sale was executed in New Israeli Shekels; the filing states the exchange rate on the transaction date was 3.033 ILS to $1.000.
  • Remaining ownership: Following the transactions, Gal directly beneficially owns 18,539 ordinary shares.
  • Remaining options: After the exercise, Gal holds 500 stock options (right to buy), with an expiration date of November 22, 2026.
  • Option grant date: The exercised options became exercisable on August 22, 2022, and were set to expire November 22, 2026.

Nayax CLO Reports Same-Day Option Exercise and Share Sale

According to the Form 4 filed with the SEC on September 17, 2026, Omer Gal, identified as the CLO (Chief Legal Officer) of Nayax Ltd., executed a same-day exercise-and-sell transaction on September 16, 2026. The filing states that Gal exercised stock options covering 1,500 ordinary shares at an exercise price of $21.352 per share. As noted in the filing's explanations, this exercise price is denominated in New Israeli Shekels, and the U.S. dollar figure reflects the exchange rate on the grant date.

The filing further discloses that the 1,500 shares acquired through the option exercise were sold on the same date at a price of $45.1698 per share. The sale was conducted on the Tel Aviv Stock Exchange in New Israeli Shekels, with the filing reporting an exchange rate of 3.033 ILS to $1.000 on the transaction date. The filing notes that "the options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I."

Following both transactions, Gal's direct beneficial ownership stood at 18,539 ordinary shares, according to the filing. In Table II, the filing also reports that 500 stock options remain outstanding, carrying the same $21.352 exercise price and an expiration date of November 22, 2026. The Form 4 was signed by Meirav Shemesh on behalf of Oppenheimer Israel, as attorney-in-fact, on September 17, 2026.

What Was Disclosed

The filing reports a same-day option exercise and sale of 1,500 Nayax ordinary shares by CLO Omer Gal on September 16, 2026, leaving him with 18,539 shares and 500 remaining stock options directly held.